180 Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07M Sell
226,383
-1,588
-0.7% -$19K 0.31% 83
2026
Q1
$1.37M Buy
227,971
+60,213
+36% +$453K 0.16% 142
2025
Q4
$1.2M Buy
167,758
+52,187
+45% +$412K 0.14% 152
2025
Q3
$1.23M Buy
115,571
+2,217
+2% +$21.8K 0.15% 141
2025
Q2
$1.1M Buy
113,354
+49,559
+78% +$511K 0.15% 140
2025
Q1
$950K Buy
63,795
+5,502
+9% +$84.6K 0.15% 144
2024
Q4
$870K Buy
58,293
+16,697
+40% +$272K 0.14% 144
2024
Q3
$796K Sell
41,596
-1,400
-3% -$29K 0.13% 165
2024
Q2
$898K Sell
42,996
-3,107
-7% -$61.7K 0.15% 140
2024
Q1
$867K Buy
46,103
+16
+0% +$275 0.16% 136
2023
Q4
$678K Buy
46,087
+29,189
+173% +$397K 0.14% 155
2023
Q3
$293K Buy
+16,898
New +$352K 0.07% 267

Other funds holding OGN

180 Wealth Advisors's OGN Position: Q2 2026 in Review

180 Wealth Advisors reduced its Organon & Co (OGN) stake by 0.7% in Q2 2026, selling an estimated $19K and leaving 226,383 shares worth $3.07M. The position accounts for 0.31% of the portfolio, ranked #83.

180 Wealth Advisors first reported a position in OGN in Q3 2023 and has held it in 12 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • 180 Wealth Advisors held 226,383 shares of Organon & Co worth $3.07M as of Q2 2026.
  • 180 Wealth Advisors sold 1,588 Organon & Co shares in Q2 2026, an estimated $19K.
  • Organon & Co made up 0.31% of 180 Wealth Advisors's portfolio in Q2 2026, its #83 holding.
  • 180 Wealth Advisors first reported a position in Organon & Co in Q3 2023 and has held it in 12 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.